Alphatec Holdings, Inc. (ATEC)
USD 10.01
(-1.96%)
USD 10.01
(-1.96%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 310.2 Million USD | 9.01% |
| 2022 | 233.05 Million USD | 47.73% |
| 2021 | 157.76 Million USD | 53.91% |
| 2020 | 102.5 Million USD | 32.1% |
| 2019 | 77.59 Million USD | 22.7% |
| 2018 | 63.23 Million USD | 1.45% |
| 2017 | 62.33 Million USD | -18.13% |
| 2016 | 76.13 Million USD | -37.36% |
| 2015 | 121.53 Million USD | -16.27% |
| 2014 | 145.14 Million USD | 15.14% |
| 2013 | 126.05 Million USD | 0.43% |
| 2012 | 125.51 Million USD | 7.34% |
| 2011 | 116.93 Million USD | 3.65% |
| 2010 | 112.81 Million USD | 34.08% |
| 2009 | 84.14 Million USD | 30.03% |
| 2008 | 64.7 Million USD | 28.88% |
| 2007 | 50.2 Million USD | 3.94% |
| 2006 | 48.3 Million USD | 96.33% |
| 2005 | 24.6 Million USD | 99.04% |
| 2004 | 12.36 Million USD | 13.5% |
| 2003 | 10.89 Million USD | 59.27% |
| 2002 | 6.83 Million USD | -15.75% |
| 2001 | 8.11 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 79.46 Million USD | 0.37% |
| 2024 Q3 | 102.72 Million USD | 24.19% |
| 2024 Q2 | 82.71 Million USD | 4.09% |
| 2023 FY | 254.06 Million USD | 9.01% |
| 2023 Q2 | 64.54 Million USD | -8.35% |
| 2023 Q3 | 80.04 Million USD | 24.03% |
| 2023 Q4 | 79.17 Million USD | -1.09% |
| 2023 Q1 | 70.42 Million USD | 2.29% |
| 2022 Q2 | 55.47 Million USD | 12.72% |
| 2022 Q4 | 68.85 Million USD | 15.68% |
| 2022 FY | 233.05 Million USD | 47.73% |
| 2022 Q1 | 49.21 Million USD | 8.82% |
| 2022 Q3 | 59.51 Million USD | 7.28% |
| 2021 Q2 | 41.06 Million USD | 28.9% |
| 2021 Q4 | 45.22 Million USD | 14.16% |
| 2021 FY | 157.76 Million USD | 53.91% |
| 2021 Q1 | 31.85 Million USD | 1.49% |
| 2021 Q3 | 39.61 Million USD | -3.53% |
| 2020 Q2 | 20.84 Million USD | -0.9% |
| 2020 Q3 | 29.23 Million USD | 40.28% |
| 2020 FY | 102.5 Million USD | 32.1% |
| 2020 Q4 | 31.39 Million USD | 7.37% |
| 2020 Q1 | 21.03 Million USD | -5.3% |
| 2019 Q3 | 19.93 Million USD | 5.54% |
| 2019 Q2 | 18.88 Million USD | 13.99% |
| 2019 Q1 | 16.56 Million USD | -0.02% |
| 2019 FY | 77.59 Million USD | 22.7% |
| 2019 Q4 | 22.2 Million USD | 11.41% |
| 2018 Q3 | 14.91 Million USD | 4.51% |
| 2018 Q4 | 16.57 Million USD | 11.12% |
| 2018 FY | 63.23 Million USD | 1.45% |
| 2018 Q1 | 13.57 Million USD | -11.27% |
| 2018 Q2 | 14.27 Million USD | 5.16% |
| 2017 Q4 | 15.29 Million USD | 5.39% |
| 2017 FY | 62.33 Million USD | -18.13% |
| 2017 Q3 | 14.51 Million USD | -7.85% |
| 2017 Q2 | 15.74 Million USD | -6.14% |
| 2017 Q1 | 16.77 Million USD | 14.71% |
| 2016 FY | 76.13 Million USD | -37.36% |
| 2016 Q1 | 31.22 Million USD | -0.84% |
| 2016 Q4 | 14.62 Million USD | -7.79% |
| 2016 Q3 | 15.86 Million USD | -43.94% |
| 2016 Q2 | 28.29 Million USD | -9.4% |
| 2015 Q1 | 33.31 Million USD | -12.56% |
| 2015 Q4 | 31.49 Million USD | 9.2% |
| 2015 FY | 121.53 Million USD | -16.27% |
| 2015 Q2 | 27.88 Million USD | -16.28% |
| 2015 Q3 | 28.84 Million USD | 3.42% |
| 2014 Q3 | 36.74 Million USD | 0.48% |
| 2014 FY | 145.14 Million USD | 15.14% |
| 2014 Q4 | 38.09 Million USD | 3.69% |
| 2014 Q1 | 33.74 Million USD | -5.49% |
| 2014 Q2 | 36.56 Million USD | 8.38% |
| 2013 Q4 | 35.69 Million USD | 44.74% |
| 2013 FY | 126.05 Million USD | 0.43% |
| 2013 Q3 | 24.66 Million USD | -24.16% |
| 2013 Q1 | 33.17 Million USD | 1.28% |
| 2013 Q2 | 32.51 Million USD | -1.97% |
| 2012 Q4 | 32.75 Million USD | 10.54% |
| 2012 Q1 | 31.81 Million USD | 27.73% |
| 2012 Q3 | 29.63 Million USD | -1.86% |
| 2012 FY | 125.51 Million USD | 7.34% |
| 2012 Q2 | 30.19 Million USD | -5.1% |
| 2011 Q3 | 30.2 Million USD | 1.16% |
| 2011 FY | 116.93 Million USD | 3.65% |
| 2011 Q4 | 24.91 Million USD | -17.53% |
| 2011 Q2 | 29.86 Million USD | -6.54% |
| 2011 Q1 | 31.95 Million USD | 3.94% |
| 2010 Q1 | 23.96 Million USD | 5.58% |
| 2010 FY | 112.81 Million USD | 34.08% |
| 2010 Q2 | 28.83 Million USD | 20.31% |
| 2010 Q4 | 30.74 Million USD | 4.92% |
| 2010 Q3 | 29.3 Million USD | 1.62% |
| 2009 Q4 | 22.69 Million USD | 9.07% |
| 2009 Q2 | 20.85 Million USD | 5.41% |
| 2009 Q1 | 19.78 Million USD | 17.37% |
| 2009 FY | 84.14 Million USD | 30.03% |
| 2009 Q3 | 20.81 Million USD | -0.19% |
| 2008 Q2 | 15.83 Million USD | 3.44% |
| 2008 FY | 64.7 Million USD | 28.88% |
| 2008 Q4 | 16.85 Million USD | 0.87% |
| 2008 Q1 | 15.31 Million USD | 21.37% |
| 2008 Q3 | 16.7 Million USD | 5.5% |
| 2007 FY | 50.2 Million USD | 3.94% |
| 2007 Q2 | 11.98 Million USD | -5.41% |
| 2007 Q3 | 12.94 Million USD | 7.98% |
| 2007 Q4 | 12.61 Million USD | -2.52% |
| 2007 Q1 | 12.66 Million USD | -3.13% |
| 2006 FY | 48.3 Million USD | 96.33% |
| 2006 Q4 | 13.07 Million USD | 21.64% |
| 2006 Q1 | 11.61 Million USD | -1.59% |
| 2006 Q2 | 12.85 Million USD | 10.63% |
| 2006 Q3 | 10.75 Million USD | -16.36% |
| 2005 Q2 | 11.8 Million USD | 71.1% |
| 2005 Q4 | 11.8 Million USD | 0.0% |
| 2005 Q1 | 6.9 Million USD | 54.9% |
| 2005 Q3 | 11.8 Million USD | 0.0% |
| 2005 FY | 24.6 Million USD | 99.04% |
| 2004 Q3 | 4.45 Million USD | 0.0% |
| 2004 Q1 | 4.45 Million USD | 0.0% |
| 2004 Q2 | 4.45 Million USD | 0.0% |
| 2004 Q4 | 4.45 Million USD | -0.0% |
| 2004 FY | 12.36 Million USD | 13.5% |
| 2003 FY | 10.89 Million USD | 59.27% |
| 2002 FY | 6.83 Million USD | -15.75% |
| 2001 FY | 8.11 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -12064.824% |
| BrainsWay Ltd. | 23.09 Million USD | -1243.394% |
| Cerus Corporation | 86.4 Million USD | -259.031% |
| Envoy Medical, Inc. | -473 Thousand USD | 65682.03% |
| electroCore, Inc. | 13.22 Million USD | -2245.403% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -508429.508% |
| IceCure Medical Ltd | 1.3 Million USD | -23761.769% |
| Inogen, Inc. | 126.69 Million USD | -144.835% |
| OrthoPediatrics Corp. | 111.25 Million USD | -178.827% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 5227.322% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 655421.531% |
| MaxCyte, Inc. | 36.54 Million USD | -748.802% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -67849.934% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -364587.28% |
| Orthofix Medical Inc. | 486.27 Million USD | 36.208% |
| PAVmed Inc | -3.96 Million USD | 7917.616% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 5755.479% |
| RxSight, Inc. | 53.76 Million USD | -476.961% |
| Sight Sciences, Inc. | 69.17 Million USD | -348.432% |
| SI-BONE, Inc. | 109.42 Million USD | -183.498% |
| TELA Bio, Inc. | 40.11 Million USD | -673.342% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -104.166% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -3650.49% |
| Acutus Medical, Inc. | -3.13 Million USD | 9988.524% |
| Talis Biomedical Corporation | 371 Thousand USD | -83512.668% |
| Spectral AI, Inc. | 7.88 Million USD | -3836.586% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 4805.749% |
| CVRx, Inc. | 33.03 Million USD | -838.899% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -41846.193% |
| Bioventus Inc. | 328.19 Million USD | 5.482% |
| Venus Concept Inc. | 52.16 Million USD | -494.635% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -1850.226% |
| LivaNova PLC | 771.25 Million USD | 59.779% |
| 908 Devices Inc. | 25.32 Million USD | -1125.034% |
| Nemaura Medical Inc. | -1.47 Million USD | 21110.883% |
| NeuroPace, Inc. | 48.12 Million USD | -544.618% |
| LENSAR, Inc. | 21.1 Million USD | -1369.669% |
| Apyx Medical Corporation | 14.12 Million USD | -2096.594% |
| Cutera, Inc. | 41.49 Million USD | -647.585% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -1580.315% |
| BioSig Technologies, Inc. | 18 Thousand USD | -1723250.0% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -200.911% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -2178.559% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 65.083% |
| Axonics, Inc. | 274.55 Million USD | -12.984% |
| Outset Medical, Inc. | 29 Million USD | -969.666% |
| IRIDEX Corporation | 21.8 Million USD | -1322.493% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -336.604% |
| IRadimed Corporation | 50.15 Million USD | -518.448% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -107984.669% |
| INVO Bioscience, Inc. | 1.08 Million USD | -28460.183% |
| Telesis Bio, Inc. | 16.95 Million USD | -1730.106% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -175.044% |
| Varex Imaging Corporation | 256.9 Million USD | -20.749% |
| Quipt Home Medical Corp. | 163.84 Million USD | -89.327% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 76504.68% |
| Pulmonx Corporation | 50.75 Million USD | -511.213% |
| Dynatronics Corporation | 7.63 Million USD | -3962.919% |
| Modular Medical, Inc. | -768 Thousand USD | 40491.016% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -5491.258% |
| Semler Scientific, Inc. | 61.2 Million USD | -406.868% |
| InMode Ltd. | 411.34 Million USD | 24.587% |
| Bruker Corporation | 1.51 Billion USD | 79.549% |
| Cytosorbents Corporation | 22.39 Million USD | -1285.328% |
| DexCom, Inc. | 2.28 Billion USD | 86.448% |
| Align Technology, Inc. | 2.71 Billion USD | 88.59% |
| Viveve Medical, Inc. | 620 Thousand USD | -49932.742% |
| ZimVie Inc. | 290.38 Million USD | -6.825% |
| Movano Inc. | -158 Thousand USD | 196431.013% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -183.482% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -364587.28% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 15.635% |
| Profound Medical Corp. | 4.51 Million USD | -6771.988% |
| Insulet Corporation | 1.15 Billion USD | 73.256% |
| enVVeno Medical Corporation | -546 Thousand USD | 56913.736% |
| Surmodics, Inc. | 93.05 Million USD | -233.365% |
| iCAD, Inc. | 14.53 Million USD | -2034.033% |
| Nuwellis, Inc. | 4.98 Million USD | -6125.226% |
| Biotricity, Inc. | 8.35 Million USD | -3612.214% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 6.511% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 86493.804% |
| InspireMD, Inc. | 1.8 Million USD | -17066.74% |
| PAVmed Inc. | -3.96 Million USD | 7917.616% |
| BIOLASE, Inc. | 16.72 Million USD | -1754.837% |
| Beyond Air, Inc. | -1.3 Million USD | 23833.971% |
| FONAR Corporation | 45.14 Million USD | -587.201% |
| AxoGen, Inc. | 127.87 Million USD | -142.585% |
| Vivani Medical, Inc. | -357 Thousand USD | 86991.597% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -58.97% |
| Inari Medical, Inc. | 434.56 Million USD | 28.617% |
| UFP Technologies, Inc. | 112.22 Million USD | -176.412% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -2477757.656% |
| Tenon Medical, Inc. | 1.24 Million USD | -24896.213% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 383066.667% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -11707.86% |
| AdaptHealth Corp. | 479.56 Million USD | 35.316% |
| Sintx Technologies, Inc. | 1.84 Million USD | -16731.416% |
| NanoVibronix, Inc. | 1.53 Million USD | -20082.368% |
| Quanterix Corporation | 70.64 Million USD | -339.095% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 76504.68% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -2106.28% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -487.728% |
| TransMedics Group, Inc. | 154.09 Million USD | -101.309% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -6866.158% |
| NeuroMetrix, Inc. | 3.94 Million USD | -7758.387% |
| Hyperfine, Inc. | 4.75 Million USD | -6420.98% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -189.972% |
| Biomerica, Inc. | 611 Thousand USD | -50669.722% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -644.117% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 39820.983% |
| Silk Road Medical, Inc | 127.08 Million USD | -144.089% |